BRIACELL THERAP (BCTX) vs LianBio Sponsored ADR (LIANY)

BRIACELL THERAP and LianBio Sponsored ADR are both Biotechnology companies. BRIACELL THERAP and LianBio Sponsored ADR are of similar size ($37.2M and $34.2M). LianBio Sponsored ADR trades at the lower P/E: 0.0× against 1.9×. Across the 10 metrics below, LianBio Sponsored ADR leads on 9 and BRIACELL THERAP on 1.

Valuation

Metric BCTX LIANY Biotechnology median
P/E 1.94 0.02 7.88
P/S n/m n/m 11.47
P/B 1.34 0.01 2.52
Price to free cash flow n/m 0.03 21.16
EV/EBITDA n/m 5.71 0.74
EV/Sales n/m n/m 10.73
Earnings yield 51.65% 4,811.17% (28.84%)
Free cash flow yield (100.28%) 3,996.57% (23.03%)

Profitability

Metric BCTX LIANY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) 70.96% (57.72%)
Return on assets (139.20%) 66.19% (49.22%)
Return on invested capital (3,311.00%) (450.47%) 0.00%

Growth

Metric BCTX LIANY Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (43.04%) 75.44% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.07 17.03 4.73
Net debt to EBITDA 0.66 7.41 0.96

Dividend

Metric BCTX LIANY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCTX LIANY Biotechnology median
Market cap 37.24m 34.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack